Kure Care, a division of Veracor Group LLC, urges Medicare beneficiaries with chronic wounds to seek regenerative treatment before January 1, 2026 Medicare reimbursement changes. The company offers treatments through 500+ certified specialists nationwide.

Miami, United States, November 19, 2025 -- In a recent announcement, Kure Care urges Medicare beneficiaries with chronic wounds to seek regenerative treatment before January 1, 2026, when Medicare reimbursement changes take effect. CEO Kenton Gray issued the advisory in response to upcoming adjustments that may affect approximately 10.5 million Medicare beneficiaries with chronic wounds nationwide, potentially limiting access to fully-covered advanced therapies that currently deliver positive healing outcomes.

More details can be found at https://curewounds.com

According to Kure Care, their regenerative treatments heal wounds 90% faster than traditional methods while reducing treatment time by 60%, addressing diabetic foot ulcers, venous leg ulcers, and pressure wounds prevalent among Medicare beneficiaries. The company has established a nationwide network of 500+ certified wound care specialists to ensure accessibility for patients who need intervention before coverage changes take effect—though, the company emphasizes, individual results may vary.

Financial accessibility lies at the heart of this recent advisory; Kure Care reports that 95% of qualified patients receive full Medicare coverage for treatments. The company has developed a platform that combines advanced regenerative treatments with Medicare billing support, streamlining the coverage process for both patients and providers while ensuring compliance with documentation requirements.

The wound care platform integrates regenerative treatments with advanced provider support tools, including real-time analytics and patient progress tracking through a dedicated provider dashboard. Providers can monitor wound healing rates, manage Medicare documentation requirements, and access billing templates designed for compliance. This model differs from traditional wound care approaches that often leave providers navigating complex reimbursement processes without adequate support.

To validate the efficacy of their approach, Kure Care has compiled a range of case studies and made them available to patients via their website. One patient reported meaningful improvement of her wound after 6 weeks of treatment, while another reported the complete disappearance of a venous leg ulcer after his course of treatment.

Patients can access these treatments through a four-step pathway: checking eligibility via an online assessment, finding a provider from the nationwide network, starting a personalized treatment plan, and tracking progress with real-time monitoring. This process removes barriers for Medicare beneficiaries who may be unfamiliar with advanced wound care options, making treatment accessible to those who need it most.

For more information, visit https://curewounds.com

Contact Info:
Name: Kenton Gray
Email: Send Email
Organization: Kure Care a division of Veracor Group LLC
Address: 1150 NW 72ND AVE TOWER 1 STE 455 #20073 , Miami, FL 33126, United States
Website: https://curewounds.com

Source: PressCable

Release ID: 89176437

If you come across any problems, discrepancies, or concerns related to the content contained within this press release that necessitate action or if a press release requires takedown, we strongly encourage you to reach out without delay by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our committed team will be readily accessible round-the-clock to address your concerns within 8 hours and take appropriate actions to rectify identified issues or support with press release removals. Ensuring accurate and reliable information remains our unwavering commitment.